Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer

FU Rui; WU Yi-long

doi:10.12019/j.issn.1671-5144.202410002

FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine. DOI: 10.12019/j.issn.1671-5144.202410002

Citation:

FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine. DOI: 10.12019/j.issn.1671-5144.202410002

Citation:

FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine. DOI: 10.12019/j.issn.1671-5144.202410002

Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer

FU Rui,
WU Yi-long

Graphical Abstract

Abstract

FullText(HTML)

References (8)

Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer

Catalog

Export File

Citation

Format

Content